Oncopeptides AB (publ) (STO: ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.210
+0.035 (1.61%)
Aug 30, 2024, 5:29 PM CET

Oncopeptides AB Revenue

Oncopeptides AB had revenue of -1.00K SEK in the twelve months ending June 30, 2024, down -100.02% year-over-year. In the year 2023, Oncopeptides AB had annual revenue of 721.00K, down -94.37%.

Revenue (ttm)
-1.00K
Revenue Growth
-100.02%
P/S Ratio
22.25
Revenue / Employee
318.94K
Employees
57
Market Cap
475.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023721.00K-12.08M-94.37%
Dec 31, 202212.80M-9.61M-42.89%
Dec 31, 202122.41M-14.71M-39.63%
Dec 31, 202037.12M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Jun 30, 2012 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca PLC 520.76B
ABB Ltd 342.58B
Investor AB (publ) 240.73B
Investor AB (publ) 240.73B
Atlas Copco AB 177.12B
Atlas Copco AB 177.12B
AB Volvo (publ) 552.20B
AB Volvo (publ) 552.20B
Revenue Rankings